US M&A and equity raisings
3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds
Deals dated after 30 September 2026 are still being collected.
24 deals · US$77bndisclosed · Diagnostics · Clear
Columns
| Date | Target | Vendor | Acquirer | Type | Status | Value US$m | Sector | Advisers |
|---|---|---|---|---|---|---|---|---|
| Jul 2025 | DiamiR Biosciences Corp. | – | Aptorum Group | Merger | Completed | – | Diagnostics+1 | H.C. Wainwright & Co. (sell-side) |
| Jul 2025 | BD Biosciences & Diagnostic Solutions business | Becton, Dickinson and Company | Waters | Asset sale | Completed | 18,800.0 | Life Sciences+2 | Citi (sell-side)Evercore (sell-side)Wachtell, Lipton, Rosen & Katz (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Barclays (buy-side)Kirkland & Ellis (buy-side) |
| Nov 2025 | Exact Sciences | – | Abbott | Acquisition | Announced | 23,000.0 | Diagnostics | Centerview Partners (sell-side)XMS Capital Partners (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Wachtell, Lipton, Rosen & Katz (buy-side) |
| Dec 2025 | Freenome Holdings | – | Perceptive Capital Solutions Corp | Merger | Completed | 725.0 | Diagnostics+2 | TD Securities (sell-side)Guggenheim Securities (sell-side)BTIG (sell-side)Goodwin (sell-side)Greenberg Traurig (sell-side)Richards, Layton & Finger (sell-side)H.C. Wainwright & Co. (sell-side)Jefferies (buy-side)Leerink Partners (buy-side)Cooley (buy-side)Ropes & Gray (buy-side)Maples Group (buy-side)Ogier (buy-side)Scalar (buy-side) |
| Dec 2025 | Bako Diagnostics selected assets | – | Fulgent Genetics | Acquisition | Completed | 56.9 | Diagnostics+1 | Latham & Watkins (sell-side)Piper Sandler (buy-side)Mintz (buy-side) |
| Dec 2025 | FONAR | – | Timothy R. Damadian | Acquisition | Announced | – | Medtech+2 | Marshall & Stevens (sell-side)DLA Piper (sell-side) |
| 2026 | Sebia | – | Warburg Pincus | Stake | Announced | – | Diagnostics | Moelis & Company (buy-side) |
| Jan 2026 | Lantheus SPECT business | Lantheus | SHINE Technologies | Asset sale | Announced | – | Pharma+2 | Solomon Partners (sell-side) |
| Feb 2026 | LKC Technologies | DW Healthcare Partners | AMETEK | Acquisition | Announced | – | Medtech+2 | William Blair (sell-side) |
| Feb 2026 | Masimo | – | Danaher | Acquisition | Announced | 9,900.0 | Medtech+1 | McDermott Will & SchulteCenterview Partners (sell-side)Morgan Stanley (sell-side)Sullivan & Cromwell (sell-side)White & Case (sell-side)Longacre Square Partners (sell-side)Citi (buy-side)Kirkland & Ellis (buy-side) |
| Mar 2026 | Biocare Medical | – | Agilent Technologies | Acquisition | Announced | 950.0 | Diagnostics+1 | Sullivan & Cromwell (buy-side) |
| Apr 2026 | Thermo Fisher Scientific's microbiology division | Thermo Fisher Scientific | Astorg | Asset sale | Announced | 1,075.0 | Diagnostics+1 | Cravath, Swaine & Moore (sell-side)Perella Weinberg Partners (sell-side)Latham & Watkins (buy-side)Moelis & Company (buy-side) |
| Apr 2026 | Naveris | – | CareDx | Acquisition | Announced | 160.0 | Diagnostics+1 | J.P. Morgan (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Goldman Sachs (buy-side)Fenwick & West (buy-side) |
| May 2026 | PathAI | – | Roche | Acquisition | Pending | 750.0 | Healthcare Software+2 | Latham & Watkins (sell-side)Davis Polk (buy-side) |
| Jun 2026 | Vesica Health | – | Photocure ASA | Acquisition | Completed | 30.5 | Diagnostics | DNB Carnegie (buy-side)Morgan Lewis (buy-side)Selmer (buy-side) |
| Jun 2026 | Ignite Proteomics | Aditxt | Proposed Ignite Proteomics Inc. holding company | Merger | Pending | 150.0 | Life Sciences+2 | Ladenburg Thalmann |
| Jun 2026 | Bio-Techne | – | Merck KGaA | Acquisition | Pending | 11,300.0 | Life Sciences+1 | Goldman Sachs (sell-side)Sidley Austin (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side)Guggenheim Securities (buy-side)J.P. Morgan (buy-side)Sullivan & Cromwell (buy-side) |
| Jul 2026 | Dreampath Diagnostics | – | Halma | Acquisition | Announced | – | Diagnostics+1 | Latham & Watkins (sell-side) |
| Jul 2026 | VitalRads | Thrive | Zoetis | Acquisition | Announced | – | Animal Health+1 | Guggenheim Securities (sell-side) |
| Jul 2026 | XpresSpa Holdings | XWELL | Express Wellness Group | Acquisition | Announced | 13.0 | Consumer Services+2 | Roth Capital Partners (sell-side)Haynes Boone (sell-side)Dechert (buy-side) |
| Jul 2026 | Personalis | – | Tempus AI | Acquisition | Announced | 1,900.0 | Diagnostics+2 | Centerview Partners (sell-side)TD Securities (sell-side)Cooley (sell-side)Morgan Stanley (buy-side)Latham & Watkins (buy-side) |
| Aug 2026 | Lantheus Holdings | – | Curium US Holdings | Acquisition | Announced | 8,000.0 | Radiopharmaceuticals+1 | Morgan Stanley (sell-side)BofA Securities (sell-side)Solomon Partners (sell-side)Covington & Burling (sell-side)Ropes & Gray (sell-side)Jefferies (buy-side)J.P. Morgan (buy-side)PJT Partners (buy-side)Kirkland & Ellis (buy-side)Arnold & Porter (buy-side) |
| Sep 2026 | MLM Medical Labs | – | Labcorp | Acquisition | Announced | – | Clinical Trial Services+1 | William BlairEvercore (buy-side)Pierson Ferdinand (buy-side)Hogan Lovells Cadwalader (buy-side) |
| Oct 2026 | Select assets of BioReference Health | OPKO Health | Labcorp | Asset sale | Announced | – | Diagnostics+1 | Lazard |
Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built